Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resmed CDI RSMDF

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.


OTCPK:RSMDF - Post by User

Bullboard Posts
Next >>
Post by edwardebreen15on Aug 22, 2022 8:35am
210 Views
Post# 34910768

Respiratory Care Devices Market Analysis & Forecast 2021-26

Respiratory Care Devices Market Analysis & Forecast 2021-26

According to IMARC Group’s latest report, titled “Respiratory Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global market exhibited strong growth during 2015-2020. Respiratory care devices are the medical equipment that are utilized for the diagnosis, assessment, treatment, and care of patients suffering from various pulmonary diseases. They include nebulizers, inhalers, spirometers, positive airway pressure (PAP) devices, humidifiers, etc. Respiratory care devices are designed to perform diagnostic, therapeutic, and monitoring functions. They help in ensuring a smooth respiration process in patients by providing adequate amounts of oxygen to the lungs and preventing any blockages.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/respiratory-care-devices-market/requestsample

 

The rising incidences of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, etc., are among the primary factors driving the respiratory care devices market. Moreover, the escalating number of smokers and the inflating rate of alcohol consumption are increasing the prevalence of lung cancer and several other severe respiratory conditions. This, in turn, is further catalyzing the market growth. Besides this, the elevating instances of premature births are propelling the product demand to treat newborn respiratory distress syndrome (NRDS). Additionally, the continuous development of miniature and customizable product variants is expected to fuel the respiratory care devices market over the forecasted period. Looking forward, IMARC Group expects the global respiratory care devices market to grow at a CAGR of around 11% during 2021-2026.

 

Checkout Now: https://www.imarcgroup.com/checkout?id=1623&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Philips Healthcare
  • ResMed
  • Chart Industries Inc.
  • Hamilton Medical
  • Medtronic, Masimo
  • Drgerwerk
  • Invacare Corporation
  • Allied Healthcare Products Inc
  • 3B Medical Inc.
  • Air Liquide
  • Fisher & Paykel Healthcare
  • GE Healthcare
  • Vyaire Medical Inc.
  • Rotech Healthcare Inc.

Market Segmentation:

 

Breakup by Product:

  • Therapeutic Devices               
    • Positive Airway Pressure (PAP) Devices        
    • Ventilators  
    • Nebulizers   
    • Humidifiers 
    • Inhalers      
    • Other
  • Monitoring Devices       
    • Pulse Oximeters             
    • Gas Analyzers
    • Others                                     
  • Diagnostic Devices       
    • Spirometers
    • Polysomnography Devices        
    • Peak Flow Meters  
    • Others
  • Consumables and Accessories          
    • Masks        
    • Disposable Resuscitators
    • Breathing Circuits
    • Tracheostomy Tubes      
    • Nasal Cannulas
    • Others

Breakup by Indication:

  • Chronic Obstructive Pulmonary Disease (COPD)              
  • Asthma               
  • Sleep Apnea                  
  • Infectious Disease         
  • Others

Breakup by End-User

  • Hospitals     
  • Home Care Settings
  • Ambulatory Care Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figureshttps://www.imarcgroup.com/respiratory-care-devices-market

 

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

 

Key highlights of the report:                                                    

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

High-performance Liquid Chromatography Market: https://www.imarcgroup.com/high-performance-liquid-chromatography-market

H1n1 Vaccines Market: https://www.imarcgroup.com/h1n1-vaccines-market

Point-of-care Diagnostics Market: https://www.imarcgroup.com/point-of-care-diagnostics-market

Negative Pressure Wound Therapy Market: https://www.imarcgroup.com/negative-pressure-wound-therapy-market

Bioinformatics Market: https://www.imarcgroup.com/bioinformatics-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Bullboard Posts
Next >>